Objective: Sinonasal malignant melanoma is a relatively rare malignancy with poor prognosis, and effective treatments remain elusive. This analysis aimed to explore whether post-operative radiotherapy conferred any survival advantages in patients with this disease when compared with surgery alone.Methods: Published studies were identified by searching four electronic databases. The endpoints evaluated were: rates of overall survival, disease-free survival and local control.Results: Twenty-eight studies including 1392 patients were identified. The results indicated that post-operative radiotherapy led to a significantly better three-year overall survival rate (p= 0.02), and suggested a borderline significant benefit for five-year overall survival (p= 0.05), when compared with surgery alone. However, no statistical advantage was found for disease-free survival, local control or one-year overall survival.Conclusion: This meta-analysis indicated that adjuvant radiotherapy prolonged survival, but showed no benefit for disease-free survival or local control.
The EGFR-targeting cancer therapies are commonly facing drug resistance, mostly due to mutations. Gene therapy with artificial microRNA targeting EGFR conserved sequence may avoid such problem. In this study, we constructed a recombinant adenovirus expressing EGFR-targeting artificial microRNA and active revCASP3 (Ad-EC), under the control of tumor-specific SLPI promoter, and evaluated its inhibitory effect on HEP-2 cancer cells both in vitro and in vivo. MTT assay showed that cell growth inhibition rate at 72h was 44.0% in Ad-EC group at MOI 50, while the rate was 7.7% in the control virus Ad-GFP group and 3.6% in Cetuximab (500 μg/ml) group respectively. Flow cytometry analysis revealed the late apoptotic cells rate was 36.1% in Ad-EC group, significantly higher than 6.5% of Ad-GFP group (p < 0.001). When Ad-EC (MOI 50) was combined with CDDP (0.25 μg/ml), late apoptotic cells rate increased to 61.2%, significantly higher than each monotherapy group (P < 0.001). The real-time xCELLigence system recorded an effective cell growth inhibition in Ad-EC and CDDP groups, and more enhanced effect in Ad-EC plus CDDP group. Western blot revealed that Ad-EC could inhibit the activation of AKT pathway and ERK1/2 pathway, while Cetuximab had the AKT pathway over-activated. In vivo experiments with HEP-2 xenograft in nude mice confirmed the tumor inhibition in Ad-EC, CDDP and Ad-EC plus CDDP groups compared with PBS group (P < 0.01). Collectively, these data support the effective inhibition of cancer cells by this novel gene therapy strategy.
12 August 2020 in European Archives of Oto-Rhino-Laryngology
Background: The round window approach and the cochleostomy approach are two widely practiced methods to insert cochlear implant electrode arrays. Yet, there is no consensus on which is more minimally invasive. Objective: To compare the initial electrode impedance (EI) values and the incidence of abnormal electrodes of the round window approach and the cochleostomy approach, and to evaluate the effects of surgical techniques on the intracochlear microenvironment. Material and methods: One hundred and seventy-one patients received a unilateral Nucleus cochlear implant. Eighty-two patients were implanted using the round window approach, and 89 patients were implanted using the cochleostomy approach. EI was measured immediately after closure of the incision. Results: The round window group had lower average initial EI values than the cochleostomy group. For the EI values at each position, statistically significant differences were found in the basal-middle region (Electrode 1–14), but not in the middle-apical region (Electrode 15–22) of the electrode arrays. A lower incidence of high-impedance electrodes was found in the round window group. Conclusions: The round window approach leads to lower initial EI and less disturbance to the intracochlear microenvironment.
5 April 2021 in European Archives of Oto-Rhino-Laryngology